Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients.

Liver transplantation is an established treatment option for end-stage liver failure. To date, no consensus has been reached on the use of immunosuppressive T-cell antibody induction for preventing rejection after liver transplantation.